Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001615774-17-004964
Filing Date
2017-09-07
Accepted
2017-09-07 15:15:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 s107410_424b3.htm 424B3 181583
  Complete submission text file 0001615774-17-004964.txt   182698
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 424B3 | Act: 33 | File No.: 333-218292 | Film No.: 171073758
SIC: 8731 Services-Commercial Physical & Biological Research